Clinical Trials Sponsored by Moerae Matrix, Inc.

Total 82 results

Moerae Matrix, Inc.

Unknown

Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide (LPS)

Acute Inflammatory Response to Non-antigenic Stimulus

United Kingdom
Matrix Biomed, Inc.

Available

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

Metastatic Cancer

United States
Matrix Biomed, Inc.

Available

A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

Prostate Cancer

United States
Matrix Biomed, Inc.

Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

Mucositis | Nephrotoxicity | Ototoxicity

United States
Matrix Biomed, Inc.
MedStar Georgetown

Not yet recruiting

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Glioblastoma | Glioblastoma Multiforme

United States
DNAtrix, Inc.

Completed

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (TARGET-I)

Glioblastoma or Gliosarcoma

United States
DNAtrix, Inc.

Completed

DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas

Central Nervous System Diseases | Brain Cancer

United States
Matrix Biomed, Inc.
Prostate Oncology Specialists

Not yet recruiting

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

Prostate Cancer Recurrent | Biochemical Recurrent Prostate Cancer

United States
Megan Moran-Santa Maria

Completed

Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin

PTSD

United States
Mati Therapeutics Inc.

Completed

An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake

Dry Eye Syndromes

United States
Mati Therapeutics Inc.

Completed

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Open-Angle Glaucoma

United States
Mati Therapeutics Inc.

Completed

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Open Angle Glaucoma

Canada
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract

Pain | Inflammation

United States
Mati Therapeutics Inc.

Completed

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Glaucoma | Ocular Hypertension (OH)

United States
Mati Therapeutics Inc.

Completed

Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.

Seasonal Allergic Conjunctivitis to Ragweed

Canada
Mati Therapeutics Inc.

Withdrawn

A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Glaucoma
Daniel Moore
Ajinomoto Co., Inc.

Completed

Protein Requirements for Active Children (IAAO-C)

Healthy | Increased Metabolic Requirement

Canada
Mati Therapeutics Inc.

Completed

Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure

Elevated Intraocular Pressure (IOP)

United States
Mati Therapeutics Inc.

Completed

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Glaucoma | Ocular Hypertension (OH)

United States
Mati Therapeutics Inc.

Completed

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension (CORE)

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.
QLT Inc.

Completed

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Ocular Hypertension | Open-Angle Glaucoma

United States
Mati Therapeutics Inc.
QLT Inc.

Completed

A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Ocular Hypertension | Open-Angle Glaucoma

United States
More Foundation
DePuy Synthes Products, Inc.

Recruiting

Motions of the Bones and Activation of the Muscles of the Shoulder Girdle During Basic and Common Arm Movement

Rotator Cuff Tears

United States
Merve Sevgi INCE

Completed

Critical Shoulder Angle and Acromial Index on 3D Models

Rotator Cuff Injuries | Shoulder Injuries | Rotator Cuff Tears

Turkey
Universidad Complutense de Madrid
Sunstar, Inc.

Recruiting

Non Surgical Therapy of Periodontitis in Diabetes Patients: the Adjunctive Use of Probiotics (ProDiabet)

Diabetes | Periodontitis

Spain
DNAtrix, Inc.
Merck Sharp & Dohme LLC

Completed

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE)

Nervous System Diseases | Glioma | Glioblastoma | Neuroectodermal Tumors | Brain Cancer | Gliosarcoma | Brain Neoplasm | Malignant Brain Tumor | Neoplasm, Neuroepithelial | Neoplasm by Histologic Type | Neoplasm, Nerve Tissue

United States, Canada
US Biotest, Inc.
Tarix Pharmaceuticals

Terminated

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

HIV Infections

United States
M.D. Anderson Cancer Center
DNAtrix, Inc.

Recruiting

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Recurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Gliosarcoma | Recurrent Anaplastic Astrocytoma | IDH1 wt Allele

United States
Matrix Biomed, Inc.
The University of Texas Health Science Center, Houston

Not yet recruiting

MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia

Ataxia Telangiectasia | Ataxia Telangiectasia Louis-Bar | Ataxia Telangiectasia in Children

United States
Lawrence S. Morse, MD
Genentech, Inc.

Completed

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) (Antibody)

Age Related Macular Degeneration

United States
Martin Gutierrez
Hackensack Meridian Health; Karyopharm Therapeutics Inc

Withdrawn

Selinexor Combination Ph 1 Study

Solid Tumor Malignancy

United States
Clinica Universidad de Navarra, Universidad de...
DNAtrix, Inc.; Alcyone Lifesciences, Inc.

Completed

Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas

Neoadjuvant Therapy | Brainstem Glioma

Spain
Clinica Universidad de Navarra, Universidad de...
DNAtrix, Inc.

Terminated

DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

Glioblastoma | Glioblastoma, Adult

Spain
Clinica Universidad de Navarra, Universidad de...
DNAtrix, Inc.

Completed

Virus DNX2401 and Temozolomide in Recurrent Glioblastoma (D24GBM)

Glioblastoma Multiforme | Recurrent Tumor

Spain
DNAtrix, Inc.
H. Lee Moffitt Cancer Center and Research Institute

Suspended

DNX-2440 for Resectable Colorectal Liver Metastasis

Melanoma | Sarcoma | Breast Cancer | Gastric Cancer | Colorectal Cancer | Gastrointestinal Stromal Tumors | Periampullary Cancer | Liver Metastases | Renal Cell Cancer | Liver Metastasis Colon Cancer | Squamous Cell Carcinoma

United States
Scott Martin Miller, MD
Biosense Webster, Inc.

Terminated

Atrial Pressure Electrophysiology Pilot Study (APES)

Atrial Fibrillation

United States
Mario Negri Institute for Pharmacological Research
Leadiant Biosciences, Inc.

Completed

Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)

Hypertension | Diabetes Type 2

Italy
Akili Interactive Labs, Inc.
Landmark College; Villa Maria College

Recruiting

EndeavorOTC® Research Study in College Students

Cognition | Attention | University Students

United States
Maria del Carmen Gogeascoechea Trejo
Adhera Health, Inc.

Not yet recruiting

Randomized Clinical Trial to Evaluate the Efficacy of a Digital Intervention for Patients With Type 2 Diabetes (DIAVERA)

Diabetes Mellitus Type 2

Mexico
Hospital San Carlos, Madrid
UNC Lineberger Comprehensive Cancer Center

Completed

Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer

Breast Cancer

Spain
Johns Hopkins University
Gordon and Betty Moore Foundation; emocha Mobile Health, Inc.; Maryland Institute...

Completed

Salud al Día: Engaging Latino Parents in Pediatric Primary Care

Primary Health Care

United States
Statens Serum Institut
Quintiles, Inc.; Bill and Melinda Gates Foundation; Larix A/S

Completed

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Poliomyelitis

Dominican Republic
Integrative Medicine Institute
Beth Israel Medical Center; Southwest College of Naturopathic Medicine; Women... and other collaborators

Completed

Zinc for the Treatment of Herpes Simplex Labialis (HSL)

Herpes Simplex Labialis

United States
Public Health Foundation Enterprises, Inc.
ViiV Healthcare; San Francisco Department of Public Health; Lyon-Martin Community...

Recruiting

The Cheeky Study: A Novel Delivery System for CAB-RPV LA

HIV Infections

United States
Thomas Martin, MD
University of California, Davis; Actavis Inc.; Eugia Pharma Specialities Limited

Recruiting

Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Relapsed Multiple Myeloma

United States
Maria Liljefors
Karolinska Institutet; Swedish Institute for Infectious Disease Control; Cyto...

Completed

Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer (El-porCEA)

Colorectal Cancer

Sweden
Brain In Game scientific-technical service
University Hospital of Santa Maria, Lleida

Recruiting

Board Games Among Mild Cognitive Impairment Patients Experience (GAME Project) (GAME-Project)

Cognitive Impairment, Mild

Spain

Clinical Trials Sponsored by Moerae Matrix, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations